Bcl-2 Polyclonal Antibody

BCL2 encodes an integral outer mitochondrial membrane protein (BCL2, apoptosis regulator) that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants.

The Bcl-2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of Bcl-2 protein expression in various biological samples. This antibody is produced using a polyclonal approach, ensuring a diverse range of epitope recognition and enhanced sensitivity.

With its exceptional affinity and specificity, the Bcl-2 Polyclonal Antibody enables accurate and reliable detection of Bcl-2 protein levels in Western blotting, immunohistochemistry, and immunofluorescence applications. It exhibits minimal cross-reactivity with other related proteins, ensuring precise and specific results.

This antibody is manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure consistent performance and reproducibility. It is supplied as a liquid formulation, ready for immediate use, eliminating the need for time-consuming reconstitution.

The Bcl-2 Polyclonal Antibody is suitable for use in both research and clinical settings, aiding in the investigation of Bcl-2 protein expression in various disease states, including cancer, apoptosis, and neurodegenerative disorders. Its versatility and reliability make it an indispensable tool for scientists and clinicians alike.

Choose the Bcl-2 Polyclonal Antibody for its exceptional sensitivity, specificity, and reliability, and unlock new insights into the role of Bcl-2 protein in cellular processes and disease pathogenesis.